ConvaTec Group (OTCMKTS:CNVVY) Upgraded to Strong-Buy by Barclays

Barclays upgraded shares of ConvaTec Group (OTCMKTS:CNVVY) to a strong-buy rating in a research note published on Wednesday, Zacks.com reports.

Separately, UBS Group upgraded ConvaTec Group to a strong-buy rating in a research report on Wednesday, June 26th. Three analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, ConvaTec Group currently has an average rating of Buy and a consensus price target of $295.00.

ConvaTec Group Trading Down 2.5 %

OTCMKTS:CNVVY opened at $12.00 on Wednesday. The company’s 50 day moving average price is $12.71 and its 200-day moving average price is $13.04. ConvaTec Group has a 52 week low of $9.90 and a 52 week high of $15.40.

ConvaTec Group Cuts Dividend

The company also recently announced a dividend, which will be paid on Monday, October 21st. Investors of record on Friday, August 23rd will be paid a dividend of $0.0584 per share. The ex-dividend date of this dividend is Friday, August 23rd.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.